This event has ended. Visit the official site or create your own event on Sched.
Back To Schedule
Tuesday, September 19 • 7:00am - 9:00am
Industry-Supported Symposia: Nonadherence in Schizophrenia: Investigating the Clinical Utility of Long-Acting Injectable Antipsychotics on Treatment Adherence

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Breakfast will be served. Seating for this session is available on a first-come, firstservedbasis. Admittance is based on availability and is not guaranteed. Please planto arrive early to ensure a seat. Breakfast will only be available until 8 A.M.

Nonadherence rates among persons with schizophrenia are estimated at 50%.Nonadherence to antipsychotic treatment is a primary reason for relapse and isassociated with increased hospitalization, higher risk of suicide, longer time toremission, poor prognosis, psychiatric emergencies, incarceration, and greaterhealthcare utilization. In this session, Drs. Kane and McEvoy will lead theaudience through a case-based analysis to identify challenges to adherence,outline pharmacotherapy interventions, and review shared decision makingprinciples designed to overcome prescription nonadherence and increasepatient outcomes.

Supported by an educational grant from Alkermes, Inc.

Tuesday September 19, 2017 7:00am - 9:00am CDT
La Nouvelle Orleans AB The New Orleans Ernest N. Morial Convention Center, 900 Convention Center Boulevard New Orleans, LA 70130